Trispecific eFab-eIg T-cell engagers targeting HER2 and HER3
Trispecific antibodies have emerged as molecules for enhanced cancer immunotherapy by addressing the complexity of cancer cell biology and anti-cancer immune responses. Here, we present a novel approach to generate trispecific antibodies based on the previously developed eIg technology. These trispe...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2025-08-01
|
| Colecção: | Frontiers in Immunology |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1642454/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|